Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial


ORAL F. , BİLGİN E., BÖLEK E. Ç. , YARDIMCI G. K. , KILIÇ L.

RHEUMATOLOGY, vol.58, no.5, pp.925, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume: 58 Issue: 5
  • Publication Date: 2019
  • Doi Number: 10.1093/rheumatology/kez033
  • Title of Journal : RHEUMATOLOGY
  • Page Numbers: pp.925